BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18344403)

  • 1. Sub-acute demyelinating neuropathy associated with an NK/T cell lymphoma.
    Wills AJ; O'Connor S; McMillan A
    J Neurol Neurosurg Psychiatry; 2008 Apr; 79(4):484-5. PubMed ID: 18344403
    [No Abstract]   [Full Text] [Related]  

  • 2. Extranodal NK/T cell lymphoma, nasal type, presenting with meningeal infiltration in a Caucasian female.
    Hildyard C; Sheikh S; Eyre T; Collins G
    Br J Haematol; 2013 Dec; 163(5):550. PubMed ID: 24033120
    [No Abstract]   [Full Text] [Related]  

  • 3. A case of inflammatory demyelinating polyradiculoneuropathy associated with T-cell lymphoma.
    Wada M; Kurita K; Tajima K; Kawanami T; Kato T
    Acta Neurol Scand; 2003 Jan; 107(1):62-6. PubMed ID: 12542515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of localized nasal NK/T-cell lymphoma].
    Yamaguchi M
    Rinsho Ketsueki; 2008 Aug; 49(8):553-8. PubMed ID: 18800601
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of Burkitt lymphoma and Burkitt-like lymphoma].
    Maruyama D
    Rinsho Ketsueki; 2011 Oct; 52(10):1645-54. PubMed ID: 21971242
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment strategy of gray zone lymphomas].
    Maruyama D
    Rinsho Ketsueki; 2014 Oct; 55(10):1912-9. PubMed ID: 25297755
    [No Abstract]   [Full Text] [Related]  

  • 7. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.
    Wang ES; Straus DJ; Teruya-Feldstein J; Qin J; Portlock C; Moskowitz C; Goy A; Hedrick E; Zelenetz AD; Noy A
    Cancer; 2003 Sep; 98(6):1196-205. PubMed ID: 12973843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of B-cell non-Hodgkin lymphoma protocol CCCG-B NHL97: a report from Chinese multi-center cooperative group.
    Tang JY; Pan C; Chen J; Chen H; Wu Y; Xue H; Zhao H; Gu LJ; Fu RY; Wang YP
    Med Pediatr Oncol; 2002 Sep; 39(3):212-4. PubMed ID: 12210455
    [No Abstract]   [Full Text] [Related]  

  • 9. Non-hodgkins lymphoma.
    Mead G; Woodcock J; Young C
    Clin Evid; 2003 Jun; (9):1-21. PubMed ID: 12967352
    [No Abstract]   [Full Text] [Related]  

  • 10. Nasal-type NK/T-cell lymphoma successfully treated with ProMACE-CytaBOM therapy.
    Isogai R; Kawada A; Hashimoto K; Aragane Y; Tezuka T; Maeda Y; Kanamaru A
    Dermatology; 2004; 209(3):243-5. PubMed ID: 15459544
    [No Abstract]   [Full Text] [Related]  

  • 11. [Nasal NK/T-cell lymphoma: about two rare cases].
    Bouayad N; Oubelkacem N; Bono W; Masbah O; Bouhafa T; Elmazghi A; Khalid H
    Pan Afr Med J; 2018; 30():141. PubMed ID: 30374387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Successful treatment with high-dose methotrexate/cytarabine regimen in a patient in SMILE regimen-resistant extranodal natural killer/T-cell lymphoma].
    Saburi M; Itani K; Nagamatsu K; Miyazaki Y; Otsuka E; Urabe S; Saburi Y
    Rinsho Ketsueki; 2014 Jan; 55(1):120-4. PubMed ID: 24492044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) plus L-asparaginase as a first-line therapy improves outcomes in stage III/IV NK/T cell-lymphoma, nasal type (NTCL).
    Kim M; Kim TM; Kim KH; Keam B; Lee SH; Kim DW; Lee JS; Jeon YK; Kim CW; Heo DS
    Ann Hematol; 2015 Mar; 94(3):437-44. PubMed ID: 25300500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A brief intensive chemotherapy in T-prolymphocytic leukemia.
    Billio A; Pescosta N; Rosanelli C; Fabris P; Coser P
    Haematologica; 2000 Apr; 85(4):438-9. PubMed ID: 10756378
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary Burkitt's lymphoma of the ovary.
    Cyriac S; Srinivas L; Mahajan V; Sundersingh S; Sagar TG
    Afr J Paediatr Surg; 2010; 7(2):120-1. PubMed ID: 20431226
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristine.
    Weintraub M; Adde MA; Venzon DJ; Shad AT; Horak ID; Neely JE; Seibel NL; Gootenberg J; Arndt C; Nieder ML; Magrath IT
    J Clin Oncol; 1996 Mar; 14(3):935-40. PubMed ID: 8622042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation.
    Sun H; Savage KJ; Karsan A; Slack GW; Gascoyne RD; Toze CL; Sehn LH; Abou Mourad Y; Barnett MJ; Broady RC; Connors JM; Forrest DL; Gerrie AS; Hogge DE; Narayanan S; Nevill TJ; Nantel SH; Power MM; Sutherland HJ; Villa D; Shepherd JD; Song KW
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):341-8. PubMed ID: 25656914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab in combination with CODOX-M/IVAC: a retrospective analysis of 23 cases of non-HIV related B-cell non-Hodgkin lymphoma with proliferation index >95%.
    Mohamedbhai SG; Sibson K; Marafioti T; Kayani I; Lowry L; Goldstone AH; Linch DC; Ardeshna KM
    Br J Haematol; 2011 Jan; 152(2):175-81. PubMed ID: 21092025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of extranodal natural killer/T-cell lymphoma, nasal type, complicated by severe hemophagocytic syndrome, with dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide chemotherapy followed by autologous stem cell transplant.
    Inoue D; Nagai Y; Takiuchi Y; Nagano S; Arima H; Kimura T; Shimoji S; Mori M; Togami K; Tabata S; Yanagita S; Matsushita A; Nagai K; Maruoka H; Imai Y; Suzuki R; Takahashi T
    Leuk Lymphoma; 2010 Apr; 51(4):720-3. PubMed ID: 20233057
    [No Abstract]   [Full Text] [Related]  

  • 20. Natural killer T-cell lymphoma of the tongue.
    Cho KJ; Cho SG; Lee DH
    Ann Otol Rhinol Laryngol; 2005 Jan; 114(1 Pt 1):55-7. PubMed ID: 15697163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.